Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prosecutors Remain Aggressive In Investigating Off-Label Drug Promotion

Executive Summary

The Philadelphia U.S. Attorney's investigations of off-label promotion include examination of drug information databases

You may also be interested in...



Off-Label Promotion Cases Need Better Oversight In Justice Dept., WLF Says

Responsibility for coordination of federal off-label promotion investigations should be transferred to the Department of Justice Criminal Division to help ensure appropriate protection of First Amendment rights, the Washington Legal Foundation said in a recent petition to DoJ

Off-Label Promotion Cases Need Better Oversight In Justice Dept., WLF Says

Responsibility for coordination of federal off-label promotion investigations should be transferred to the Department of Justice Criminal Division to help ensure appropriate protection of First Amendment rights, the Washington Legal Foundation said in a recent petition to DoJ

Clinical Trial Conduct May Be Subject To DoJ Enforcement

The Department of Justice is moving into the arena of FDA regulation - including a manufacturer's conduct of clinical trials - in its enforcement of fraud statutes

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045038

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel